Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
– Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission – Exclusive licensing and supply agreements have been granted to Medexus for
